144 related articles for article (PubMed ID: 16585221)
1. PGP9.5 methylation in diffuse-type gastric cancer.
Yamashita K; Park HL; Kim MS; Osada M; Tokumaru Y; Inoue H; Mori M; Sidransky D
Cancer Res; 2006 Apr; 66(7):3921-7. PubMed ID: 16585221
[TBL] [Abstract][Full Text] [Related]
2. Microarray analysis of gene expression in metastatic gastric cancer cells after incubation with the methylation inhibitor 5-aza-2'-deoxycytidine.
Chen J; Röcken C; Klein-Hitpass L; Götze T; Leodolter A; Malfertheiner P; Ebert MP
Clin Exp Metastasis; 2004; 21(5):389-97. PubMed ID: 15672863
[TBL] [Abstract][Full Text] [Related]
3. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
4. PGP9.5 was less frequently methylated in advanced gastric carcinoma.
Mizukami H; Goto T; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Hepatogastroenterology; 2009; 56(94-95):1576-9. PubMed ID: 19950834
[TBL] [Abstract][Full Text] [Related]
5. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.
Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T
Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801
[TBL] [Abstract][Full Text] [Related]
6. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray.
Yamashita S; Tsujino Y; Moriguchi K; Tatematsu M; Ushijima T
Cancer Sci; 2006 Jan; 97(1):64-71. PubMed ID: 16367923
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of A disintegrin and metallopeptidase with thrombospondin motif type 1 by DNA hypermethylation in human gastric cancer.
Chen J; Zhang C; Xu X; Zhu X; Dai D
Mol Med Rep; 2015 Aug; 12(2):2487-94. PubMed ID: 25936341
[TBL] [Abstract][Full Text] [Related]
8. Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray.
Wu CM; Lee YS; Wang TH; Lee LY; Kong WH; Chen ES; Wei ML; Liang Y; Hwang TL
Oncol Rep; 2006 Jan; 15(1):57-64. PubMed ID: 16328034
[TBL] [Abstract][Full Text] [Related]
9. Frequent silencing of protocadherin 8 by promoter methylation, a candidate tumor suppressor for human gastric cancer.
Zhang D; Zhao W; Liao X; Bi T; Li H; Che X
Oncol Rep; 2012 Nov; 28(5):1785-91. PubMed ID: 22941331
[TBL] [Abstract][Full Text] [Related]
10. Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer.
Wang JF; Dai DQ
World J Gastroenterol; 2007 Nov; 13(43):5692-8. PubMed ID: 17963294
[TBL] [Abstract][Full Text] [Related]
11. Analysis of genes upregulated by the demethylating agent 5-aza-2'-deoxycytidine in gastric cancer cell lines.
Mikata R; Yokosuka O; Fukai K; Imazeki F; Arai M; Tada M; Kurihara T; Zhang K; Kanda T; Saisho H
Int J Cancer; 2006 Oct; 119(7):1616-22. PubMed ID: 16671088
[TBL] [Abstract][Full Text] [Related]
12. Contribution of DNA methylation and EZH2 in SRBC down-regulation in gastric cancer.
Rezaei S; Hosseinpourfeizi MA; Moaddab Y; Safaralizadeh R
Mol Biol Rep; 2020 Aug; 47(8):5721-5727. PubMed ID: 32676814
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
Bae SI; Lee HS; Kim SH; Kim WH
Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of cyclin D2 gene in gastric carcinoma.
Oshimo Y; Nakayama H; Ito R; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Oncol; 2003 Dec; 23(6):1663-70. PubMed ID: 14612939
[TBL] [Abstract][Full Text] [Related]
16. Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype.
Waraya M; Yamashita K; Ema A; Katada N; Kikuchi S; Watanabe M
PLoS One; 2015; 10(10):e0139902. PubMed ID: 26447864
[TBL] [Abstract][Full Text] [Related]
17. Association of Helicobacter pylori and diffuse type gastric cancer.
Handa Y; Saitoh T; Kawaguchi M; Misaka R; Ohno H; Tsai CR; Tani Y; Tsurui M; Yoshida H; Morita S; Midorikawa S; Sanji T
J Gastroenterol; 1996 Nov; 31 Suppl 9():29-32. PubMed ID: 8959514
[TBL] [Abstract][Full Text] [Related]
18. LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer.
Kim M; Kim JH; Jang HR; Kim HM; Lee CW; Noh SM; Song KS; Cho JS; Jeong HY; Hahn Y; Yeom YI; Yoo HS; Kim YS
Cancer Res; 2008 Sep; 68(17):7147-55. PubMed ID: 18757430
[TBL] [Abstract][Full Text] [Related]
19. Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance.
Zhang X; Li W; Li H; Ma Y; He G; Tan G
Anticancer Drugs; 2012 Sep; 23(8):856-64. PubMed ID: 22824824
[TBL] [Abstract][Full Text] [Related]
20. Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression.
Brait M; Maldonado L; Noordhuis MG; Begum S; Loyo M; Poeta ML; Barbosa A; Fazio VM; Angioli R; Rabitti C; Marchionni L; de Graeff P; van der Zee AG; Wisman GB; Sidransky D; Hoque MO
PLoS One; 2013; 8(9):e70878. PubMed ID: 24086249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
